date is 2025-07
Select an archive month  
July 2025
June 2025
May 2025
April 2025
March 2025
February 2025
January 2025
December 2024
November 2024
October 2024
September 2024
August 2024
July 2024
June 2024
May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013

Archive, 2025-07

1006 A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity
Ramasubramanian, T. S.; Adstamongkonkul, P.; Scribano, C.; Johnson, C.; Caenepeel, S.; Hrycyniak, L.; Vedder, L. C.; Dana, N.; Baltes, C.; Browning, T.; Chen, Y.-I.; Dietz, T.; Flietner, E.; Kaplewski, N.; Kellner, A.; Korrer, M.; Liu, C.; Marhefke, N.; McDonnell, P.; Nasreen, A.; Pope, V.; Prasad, A.; Richardson, J.; Schneider, S.; Schultz, M.; Sood, C.; Sunil, A.; von Euw, E.; Wait, E.; Wargowski, E.; Advani, P.; Broome, B.; Bruckbauer, A.; Godwin, A.; Kokabi, N.; Martin, R.; Robaina, M.; Toia, G.; Routh, J.; Friedl, A.; Eliceiri, K.; Szulczewski, M.; Johnson, S.; Oliner, J.; Galon, J.; Capi
10.1101/2025.07.18.663728 — cancer biology — Posted on 2025-07-18
2619 Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials
Williamson, C.; Moodley, C.; Magaret, C. A.; Giorgi, E. E.; Rolland, M.; Westfall, D. H.; Yssel, A.; Deng, W.; Rossenkhan, R.; Mkhize, N. N.; Chen, L. H.; Zhao, H.; Bhattacharya, T.; Pankow, A.; Murrell, B.; York, T.; Gwashu-Nyangiwe, A.; Ndabambi, N.; Thebus, R.; Cohen, P.; Lambson, B. E.; Kaldine, H.; Bhebhe, S.; Juraska, M.; Bai, H.; deCamp, A. C.; Miner, M.; Ludwig, J.; Molitor, C.; Beaume, N.; Matten, D.; Huang, Y.; Zhang, L.; Reeves, D. B.; Mayer, B.; Karuna, S. T.; Hural, J. A.; Morris, L.; Montefiori, D.; Bumgarner, R. E.; Moore, P.; Edlefsen, P. T.; Edupuganti, S.; Mgodi, N.; McElrath
10.1101/2025.07.01.659979 — molecular biology — Posted on 2025-07-10
2622 Clinical and molecular characterisation of primary refractoriness to atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma.
Lombardi, P.; Ramon-Gil, E.; Brunetti, L.; Manfredi, G. F.; Merces, G.; Fulgenzi, C. A. M.; DAlessio, A.; Torkpour, A.; Celsa, C.; Stefanini, B.; Yang, H.; Crowley, F.; Marron, T. U.; Saeed, A.; Pinter, M.; Scheiner, B.; Huang, Y.-H.; Lee, P.-C.; Nishida, N.; Po-Ting Lin, R.; Dalbeni, A.; Vivaldi, C.; Masi, G.; Rohlen, N.; von Felden, J.; Kaseb, A.; Galle, P. R.; Kudo, M.; Hsu, W.-F.; Rimassa, L.; Parisi, A.; Kelley, R. K.; Toyoda, H.; Pirisi, M.; Jabar, R. F.; Rakaee, M.; Cabibbo, G.; Camma, C.; Piscaglia, F.; Hwang, S.; Shin, D. J.; Li, M.; Daniele, G.; Mann, D.; Chon, H. J.; Leslie, J.; Pin
10.1101/2025.07.08.663653 — cancer biology — Posted on 2025-07-10
2915 The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosis
Ruwisch, J.; Cazes, A.; Leiber, L. M.; Borie, R.; Neubert, L.; Christian, L.; De Montpreville, V. T.; Szmul, A.; Moussa, F.; Verleden, S.; Gaedcke, S.; Hegermann, J.; Fuge, J.; Ballmaier, M.; Kamp, J. C.; Greer, M.; Braubach, P.; Werlein, C.; Ius, F.; Graalmann, T.; Aburahma, K.; de Sadaleer, L.; Egashira, R.; Ackermann, M.; Yamda, D.; Hoeper, M.; Falk, C.; Gottlieb, J.; Schiller, H.; Vanaudenaerde, B.; Seeliger, B.; Debray, M.-P.; Bernaudin, J. F.; Knudsen, L.; Bergot, E.; Jacob, J.; Mal, H.; Jonigk, D.; Dettmer, S.; Mordant, P.; Prasse, A.; Fadel, E.; Wuyts, W.; Crestani, B.; Kaminski, N.; J
10.1101/2025.07.06.663336 — cell biology — Posted on 2025-07-08